Christopher Koh
- Hepatology top 0.5%
- Hepatitis C virus research 53
- Liver Disease and Transplantation 21
- Hepatitis Viruses Studies and Epidemiology 15
- Liver Diseases and Immunity 8
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment 59
- Hepatitis B Virus Studies 47
- Immunology top 5%
- Virology top 10%
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection 9
-
- Helicobacter pylori-related gastroenterology studies 9
- Co-authors
- Theo HellerDavid E. KleinerYaron RotmanT. Jake LiangJay H. HoofnagleJoseph M. ZmudaJake T. LiangJeffrey S. Glenn
- Cited by
- HepatologyEpidemiologyImmunology
- Journals
- Gastroenterology (16 papers)Hepatology (15 papers)Alimentary Pharmacology & Therapeutics (11 papers)
- Partner nations
- United StatesCanadaTürkiye
In The Last Decade
Christopher Koh
129 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 104
- Hepatology 1.8k
- Epidemiology 2.2k
- Immunology 478
- Virology 77
- Pharmacology 126
Countries citing papers authored by Christopher Koh
This map shows the geographic impact of Christopher Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Koh more than expected).
Fields of papers citing papers by Christopher Koh
This network shows the impact of papers produced by Christopher Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Koh. The network helps show where Christopher Koh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher Koh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 7 | |
| 11 | 2019 | 7 | |
| 12 | 2019 | 31 | |
| 13 | 2019 | 27 | |
| 14 | 2019 | 13 | |
| 15 | 2019 | 4 | |
| 16 | 2019 | 7 | |
| 17 | 2019 | 6 | |
| 18 | Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC) | 2019 | 0 |
| 19 | 2017 | 103 | |
| 20 | 2014 | 81 |
About Christopher Koh
Christopher Koh is a scholar working on Hepatology, Epidemiology and Pharmacology, having authored 138 papers that have together received 3.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (59 papers), Hepatitis C virus research (53 papers), Hepatitis B Virus Studies (47 papers), Liver Disease and Transplantation (21 papers), Hepatitis Viruses Studies and Epidemiology (15 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Liver Diseases and Immunity (8 papers). The work is most often cited by research in Hepatology (1.8k citations), Epidemiology (2.2k citations) and Immunology (478 citations). Christopher Koh has collaborated with scholars based in United States, Canada and Türkiye. Frequent co-authors include Theo Heller, David E. Kleiner, Yaron Rotman, T. Jake Liang, Jay H. Hoofnagle, Joseph M. Zmuda, Jake T. Liang, Jeffrey S. Glenn, Pallavi Surana and Ben L. Da. Their work appears in journals such as Gastroenterology, Hepatology, Alimentary Pharmacology & Therapeutics, Hepatology Communications and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.